Hormone Replacement Therapy Increases Serum Levels Of Nitric Oxide End Products | 12906
ISSN: 2161-1165

Epidemiology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Hormone replacement therapy increases serum levels of nitric oxide end products

International Conference on Epidemiology and Evolutionary Genetics

Shilpika Saxena

ScientificTracks Abstracts: Epidemiol

DOI: 10.4172/2161-1165.S1.002

C ardiovascular disease is the leading cause of illness and death in women. Women appear to have greater resistance to atherosclerosis in the pre menopausal years and this is attributed in part to an estrogen dependent increase in the basal nitric oxide synthesis. Women in post menopausal years have estrogen deficiency due to the waning ovarian activity. Hormone replacement therapy potentiates the release of endothelium derived relaxation factor, Nitric oxide and thus reduces the risk of coronary artery disease in postmenopausal women. The study group included fifty postmenopausal women and the control group included fifty healthy women with regular menses. Serum levels of nitric oxide end products (NOEP)were measured in the control group and before and after hormone replacement therapy in the in the study group .Women in the study group were placed on Hormone replacement therapy (HRT) for six months. Serum NOEP levels in the study group before hormone replacement therapy (19.57 + 2.44) were significantly lower (p<0.001) than the control group (34.58 + 6.23). The serum NOEP levels increased significantly (p<0.001) after hormone replacement therapy (29.97 + 3.82) in the study group. The rise was significantly (p<0.001) in the hysterectomised post menopausal women (31.08 + 2.84).
Shilpika Saxena has completed her M.B.B.S. from Government Medical College, University of Rajasthan, India and M.D. from Armed Forces Medical College, Pune University, India, residency at Armed Forces Medical College, Pune University, India. She is currently serving as the Assistant Professor, Biochemistry in the Medical University of the Americas, Nevis.